{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T00:07:22Z","timestamp":1784333242435,"version":"3.55.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,10,8]],"date-time":"2018-10-08T00:00:00Z","timestamp":1538956800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Environ Biophys"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s00411-018-0757-2","type":"journal-article","created":{"date-parts":[[2018,10,8]],"date-time":"2018-10-08T04:24:28Z","timestamp":1538972668000},"page":"395-404","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Red bone marrow dose estimation using several internal dosimetry models for prospective dosimetry-oriented radioiodine therapy"],"prefix":"10.1007","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3856-3023","authenticated-orcid":false,"given":"Mohammad","family":"Abuqbeitah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Demir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130ffet","family":"\u00c7avdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Handan","family":"Tanyildizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nami","family":"Yeyin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lebriz","family":"Uslu-Be\u015fli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Levent","family":"Kabasakal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazenin \u0130pek","family":"I\u015f\u0131kc\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerim","family":"S\u00f6nmezo\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,8]]},"reference":[{"issue":"1","key":"757_CR1","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s13550-017-0339-3","volume":"7","author":"M Andersson","year":"2017","unstructured":"Andersson M, Johansson L, Eckerman K, Mattsson S (2017) IDAC-Dose 2.1, an Internal dosimetry program for diagnostic nuclear medicine based on the ICRP adult reference voxel phantoms. EJNMMI Res 7(1):88","journal-title":"EJNMMI Res"},{"key":"757_CR36","first-page":"171","volume":"87","author":"RS Benua","year":"1962","unstructured":"Benua RS, Cicale NR, Sonenberg M, Rawson RW (1962) The relation of radioiodine dosimetry to results and complications in the treatment of metastatic thyroid cancer. Am J Roentgenol Radium Ther Nucl Med 87:171\u2013182","journal-title":"Am J Roentgenol Radium Ther Nucl Med"},{"key":"757_CR2","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1210\/jcem.86.4.7390","volume":"86","author":"O Bernier","year":"2001","unstructured":"Bernier O, Leenhardt L, Hoang C, Aurengo A, Mary JY, Menegaux F, Enkaoua E, Turpin G, Chiras J, Saillant G, Hejblum G (2001) Survival and therapeutic modalities in patients with bone metastases of differentiated thyroid carcinomas. J Clin Endocrinol Metab 86:1568\u20131573","journal-title":"J Clin Endocrinol Metab"},{"key":"757_CR3","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1007\/s00259-006-0338-5","volume":"34","author":"B Brans","year":"2007","unstructured":"Brans B, Bodei L, Giammarile F, Linden O, Luster M, Oyen G, Tennvall J (2007) Clinical radionuclide therapy dosimetry: the quest for the \u201cHoly Gray\u201d. Eur J Nucl Med Mol Imaging 34:772\u2013786","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"757_CR4","first-page":"754","volume":"36","author":"B Breitz","year":"1995","unstructured":"Breitz B, Durham JS, Fisher DR, Weiden PL, DeNardo GL, Goodgold HM, Nelp WB (1995) Pharmacokinetics and normal organ dosimetry following intraperitoneal rhenium-186-labeled monoclonal antibody. J Nucl Med 36:754\u2013761","journal-title":"J Nucl Med"},{"key":"757_CR5","first-page":"546","volume":"53","author":"C Chiesa","year":"2009","unstructured":"Chiesa C, Castellani MR, Vellani C, Orunesu E, Negri A, Azzeroni R, Botta F, Maccauro M, Aliberti G, Seregni E, Lassmann M, Bombardieri E (2009) Individualized dosimetry in the management of metastatic differentiated thyroid cancer. Q J Nucl Med Mol Imaging 53:546\u2013561","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"757_CR6","first-page":"216","volume":"56","author":"Council of the European Union","year":"2013","unstructured":"Council of the European Union (2013) Council Directive 2013\/59\/EURATOM. Off J Eur Union 56:216","journal-title":"Off J Eur Union"},{"key":"757_CR7","first-page":"1549","volume":"45","author":"B Keizer De","year":"2004","unstructured":"De Keizer B, Hoekstra A, Konijnenberg MW, Devos F, Lambert B, Van RP, Lips M, de Klerk JH (2004) Bone marrow dosimetry and safety of high 131I activities given after recombinant human thyroid-stimulating hormone to treat metastatic differentiated thyroid cancer. J Nucl Med 45:1549\u20131554","journal-title":"J Nucl Med"},{"issue":"5","key":"757_CR8","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1160\/nukmed-0288","volume":"46","author":"C Franzius","year":"2007","unstructured":"Franzius C, Dietlein M, Biermann MF, Fruhwald M, Linden T, Bucsky P, Reiners C, Schober O (2007) Procedure guideline for radioiodine therapy and 131iodine whole-body scintigraphy in paediatric patients with differentiated thyroid cancer. Nuklearmedizin 46(5):224\u2013231","journal-title":"Nuklearmedizin"},{"key":"757_CR9","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1677\/ERC-09-0076","volume":"16","author":"H H\u00e4nscheid","year":"2009","unstructured":"H\u00e4nscheid H, Lassmann M, Luster M, Kloos RT, Reiners C (2009) Blood dosimetry from a single measurement of the whole body radioiodine retention in patients with differentiated thyroid carcinoma. Endocr Relat Cancer 16:1283\u20131289","journal-title":"Endocr Relat Cancer"},{"key":"757_CR10","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1007\/s00259-013-2387-x","volume":"40","author":"H H\u00e4nscheid","year":"2013","unstructured":"H\u00e4nscheid H, Canzi C, Eschner W, Flux G, Luster M, Strigari L, Lassmann M (2013) EANM dosimetry committee series on standard operational procedures for pretherapeutic dosimetry II. Dosimetry prior to radioiodine therapy of benign thyroid diseases. Eur J Nucl Med Mol Imaging 40:1126\u20131134","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"757_CR11","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s00259-010-1398-0","volume":"37","author":"C Hindorf","year":"2010","unstructured":"Hindorf C, Glatting G, Chiesa C, Lind\u00e9n O, Flux G (2010) EANM dosimetry committee guidelines for bone marrow and whole-body dosimetry. Eur J Nucl Med Mol Imaging 37(4):821\u2013828","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"757_CR12","unstructured":"ICRP (2002) Basic anatomical and physiological data for use in radiological protection reference values. ICRP Publication 89. Annals of ICRP, vol 32, issue 3\u20134"},{"key":"757_CR13","unstructured":"ICRP (2008) Nuclear Decay Data for Dosimetric Calculations. ICRP Publication 107. Annals of ICRP, vol 38, issue 3"},{"key":"757_CR14","unstructured":"ICRP (2009) Adult Reference Computational Phantoms. ICRP Publication 110. Annals of ICRP, vol 39, issue 2"},{"issue":"2","key":"757_CR15","first-page":"1","volume":"45","author":"ICRP","year":"2016","unstructured":"ICRP (2016) The ICRP computational framework for internal dose assessment for reference adults: specific absorbed fractions. ICRP Publication 133 Ann ICRP 45(2):1\u201374","journal-title":"ICRP Publication 133 Ann ICRP"},{"key":"757_CR16","doi-asserted-by":"publisher","first-page":"3217","DOI":"10.1210\/jc.2011-0494","volume":"96","author":"J Klubo-Gwiezdzinska","year":"2011","unstructured":"Klubo-Gwiezdzinska J, Van Nostrand D. Atkins F, Burman K, Jonklaas J, Mete M, Wartofsky L (2011) Efficacy of dosimetric versus empiric prescribed activity of 131I for therapy of differentiated thyroid cancer. J Clin Endocrinol Metab 96:3217\u20133225","journal-title":"J Clin Endocrinol Metab"},{"issue":"22","key":"757_CR17","doi-asserted-by":"publisher","first-page":"7317","DOI":"10.1088\/0031-9155\/56\/22\/020","volume":"56","author":"S Lamart","year":"2011","unstructured":"Lamart S, Bouville A, Simon SL, Eckerman KF, Melo D, Lee C (2011) Comparison of internal dosimetry factors for three classes of adult computational phantoms with emphasis on I-131 in the thyroid. Phys Med Biol 56(22):7317\u20137335","journal-title":"Phys Med Biol"},{"issue":"1","key":"757_CR18","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1093\/rpd\/ncv016","volume":"168","author":"S Lamart","year":"2016","unstructured":"Lamart S, Simon SL, Bouville A, Moroz BE, Lee C (2016) S values for 131I based on the ICRP adult voxel phantoms. Radiat Prot Dosim 168(1):92\u2013110","journal-title":"Radiat Prot Dosim"},{"key":"757_CR19","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1007\/s00259-008-0761-x","volume":"35","author":"M Lassmann","year":"2008","unstructured":"Lassmann M, H\u00e4nscheid H, Chiesa C, Hindorf C, Flux G, Luster M (2008) EANM Dosimetry Committee series on standard operational procedures for pre-therapeutic dosimetry I: blood and bone marrow dosimetry in differentiated thyroid cancer therapy. Eur J Nucl Med Mol Imaging 35:1405\u20131412","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"757_CR21","doi-asserted-by":"publisher","first-page":"R161","DOI":"10.1677\/ERC-10-0071","volume":"17","author":"M Lassmann","year":"2010","unstructured":"Lassmann M, Reiners C, Luster M (2010) Dosimetry and thyroid cancer: the individual dosage of radioiodine. Endocr Relat Cancer 17(3):R161\u2013R172","journal-title":"Endocr Relat Cancer"},{"key":"757_CR22","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s12149-007-0179-8","volume":"22","author":"JJ Lee","year":"2008","unstructured":"Lee JJ, Chung JK, Kim SE, Kang WJ, Park DJ, Lee DS, Cho BY, Lee MC (2008) Maximal safe dose of I-131 after failure of standard fixed dose therapy in patients with differentiated thyroid carcinoma. Ann Nucl Med 22:727\u2013734","journal-title":"Ann Nucl Med"},{"issue":"10","key":"757_CR23","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1007\/s00259-008-0883-1","volume":"35","author":"M Luster","year":"2008","unstructured":"Luster M, Clarke SE, Dietlein M, Lassmann M, Lind P, Oyen WG, Tennvall J, Bombardieri E (2008) Guidelines for radioiodine therapy of differentiated thyroid cancer. Eur J Nucl Med Mol Imaging 35(10):1941\u20131959","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"757_CR24","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1210\/jcem.86.4.7407","volume":"86","author":"EL Mazzaferri","year":"2001","unstructured":"Mazzaferri EL, Kloos RT (2001) Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 86(4):1447\u20131463","journal-title":"J Clin Endocrinol Metab"},{"key":"757_CR25","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1111\/j.1365-2141.1995.tb08411.x","volume":"89","author":"TC Pearson","year":"1995","unstructured":"Pearson TC, Guthrie DL, Simpson J, Chinn S, Barosi G, Ferrant A, Lewis SM, Najean Y (1995) Interpretation of measured red cell mass and plasma volume in adults: Expert Panel on Radionuclides of the International Council for Standardization in Haematology. Br J Haematol 89:748\u2013756","journal-title":"Br J Haematol"},{"issue":"4","key":"757_CR26","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s00259-010-1398-0","volume":"37","author":"M Salvatori","year":"2010","unstructured":"Salvatori M, Luster M (2010) Radioiodine therapy dosimetry in benign thyroid disease and differentiated thyroid carcinoma. Eur J Nucl Med Mol Imaging 37(4):821\u2013828","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"757_CR27","first-page":"2102","volume":"40","author":"S Shen","year":"1999","unstructured":"Shen S, DeNardo GL, Sgouros G, O\u2019Donnell RT, DeNardo SJ (1999) Practical determination of patient-specific marrow dose using radioactivity concentration in blood and body. J Nucl Med 40:2102\u20132106","journal-title":"J Nucl Med"},{"key":"757_CR28","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1089\/cbr.2005.20.126","volume":"20","author":"JA Siegel","year":"2005","unstructured":"Siegel JA (2005) Establishing a clinically meaningful predictive model of hematologic toxicity in nonmyeloablative targeted radiotherapy: practical aspects and limitations of red marrow dosimetry. Cancer Biother Radiopharm 20:126\u2013140","journal-title":"Cancer Biother Radiopharm"},{"key":"757_CR29","first-page":"37S","volume":"40","author":"JA Siegel","year":"1999","unstructured":"Siegel JA, Thomas SR, Stubbs JB, Stabin MG, Hays MT, Koral KF, Robertson JS, Howell RW, Wessels BW, Fisher DR, Weber D, Brill B (1999) MIRD pamphlet no. 16: Techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates. J Nucl Med 40:37S\u2013 61S","journal-title":"J Nucl Med"},{"key":"757_CR30","first-page":"1023","volume":"46","author":"MG Stabin","year":"2005","unstructured":"Stabin MG, Parks RB, Crowe E (2005) OLINDA\/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine. J Nucl Med 46:1023\u20131027","journal-title":"J Nucl Med"},{"issue":"11","key":"757_CR31","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.2967\/jnumed.112.106138","volume":"53","author":"MG Stabin","year":"2012","unstructured":"Stabin MG, Xu X, Emmons M, Segars W, Shi C, Fernald J (2012) RADAR reference adult, pediatric, and pregnant female phantom series for internal and external dosimetry. J Nucl Med 53(11):1807\u20131813","journal-title":"J Nucl Med"},{"key":"757_CR32","doi-asserted-by":"publisher","first-page":"5231","DOI":"10.1088\/0031-9155\/52\/17\/009","volume":"52","author":"AC Traino","year":"2007","unstructured":"Traino AC, Ferrari M, Cremonesi M, Stabin MG (2007) Influence of total-body mass on the scaling of S -factors for patient-specific, blood-based red-marrow dosimetry. Phys Med Biol 52:5231\u20135248","journal-title":"Phys Med Biol"},{"issue":"6","key":"757_CR33","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1007\/s00259-017-3649-9","volume":"44","author":"F Verburg","year":"2017","unstructured":"Verburg F, Markus L, Luca G, Michael L, Carlo C, Nicolas C, Glenn F (2017) The \u2018reset Button\u2019 revisited: why high activity 131i therapy of advanced differentiated thyroid cancer after dosimetry is advantageous for patients. Eur J Nucl Med Mol Imaging 44(6):915\u2013917","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"757_CR34","first-page":"1725","volume":"45","author":"BW Wessels","year":"2004","unstructured":"Wessels BW, Bolch WE, Bouchet LG, Breitz HB, Denardo GL, Meredith RF, Stabin MG, Sgouros G (2004) Bone marrow dosimetry using blood-based models for radiolabeled antibody therapy: a multiinstitutional comparison. J Nucl Med 45:1725\u20131733","journal-title":"J Nucl Med"},{"key":"757_CR35","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1093\/rpd\/ncr214","volume":"149","author":"J Willegaignon","year":"2012","unstructured":"Willegaignon J, Sapienza MT, Buchpiguel CA (2012) Comparison of different dosimetric methods for red marrow absorbed dose calculation in thyroid cancer therapy. Radiat Prot Dosim 149:138\u2013146","journal-title":"Radiat Prot Dosim"}],"container-title":["Radiation and Environmental Biophysics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00411-018-0757-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00411-018-0757-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00411-018-0757-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,7]],"date-time":"2019-10-07T19:24:14Z","timestamp":1570476254000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00411-018-0757-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,8]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["757"],"URL":"https:\/\/doi.org\/10.1007\/s00411-018-0757-2","relation":{},"ISSN":["0301-634X","1432-2099"],"issn-type":[{"value":"0301-634X","type":"print"},{"value":"1432-2099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,8]]},"assertion":[{"value":"22 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in the current study involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Istanbul University Cerrahpa\u015fa Medical Faculty Clinical Research Ethics Committee approved this study (document number: 83045809\/604\/02-8877).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all the individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}